Actively Recruiting
Randomized Study Comparing Autologous Stem Cell Transplant to Observation in Patients with Peripheral T-Cell Lymphoma Achieving Complete Remission After Initial Chemotherapy
Led by Eastern Cooperative Oncology Group · Updated on 2026-09-14
294
Participants Needed
165
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial studies patients with peripheral T-cell lymphoma who have achieved a complete response after initial chemotherapy. It compares the effects of high dose chemotherapy followed by an autologous stem cell transplant using the patients own stem cells to observation only. The trial aims to find out if the transplant improves progression-free survival and overall survival compared to observation alone. This is a phase III randomized study sponsored by the Eastern Cooperative Oncology Group. Participants are randomly assigned to one of two groups. One group receives standard care observation, including regular blood tests, optional bone marrow biopsies, and imaging scans such as CT or PETCT. The other group undergoes stem cell mobilization, leukapheresis to collect stem cells, high dose chemotherapy, and then an autologous stem cell transplant. Both groups have similar monitoring with blood samples and imaging throughout the study. Participants are followed closely after treatment every 3 months for 2 years, then every 6 months for 3 years, and annually up to 7 years, totaling 12 years from randomization. The study measures progression-free survival as the primary outcome, with overall survival, relapse rates, and mortality as secondary outcomes. Monitoring includes blood samples, optional bone marrow tests, and imaging to track disease status and safety over time.
CONDITIONS
Brief Title
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Research Team
P
Pamela Cogliano
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here